STM Journals Peer-reviewed research from Consortium e-Learning Network

Research & Reviews: A Journal of Drug Design & Discovery Review Article

Innovative strategies in capsule formulation from concept to market

  1. Mohd. Wasiullah Dept.of Pharmacy, Prasad Institute of Technology, Jaunpur
  2. Piyush Yadav Department of Pharmaceutical Chemistry, Prasad Institute of Technology, Jaunpur
  3. Pratibha Devi Maurya Dept.of Pharmacy, Prasad Institute of Technology, Jaunpur
  4. Sarvjeet Dept. of Pharmacy, Prasad Institute of Technology, Jaunpur,

Abstract

Innovative strategies in capsule formulation have revolutionized drug delivery and nutraceutical development, offering advanced solutions from initial concept to market release. This report explores the transformative techniques at each stage of capsule formulation, detailing novel approaches in ingredient selection, encapsulation technology, and manufacturing processes. By leveraging advancements in artificial intelligence, encapsulation methods, such as liposomal and nanoparticle technologies, and materials science, formulators can optimize the bioavailability, stability, and targeted delivery of active compounds. The paper also examines Quality by Design (QbD) principles and risk management frameworks that ensure robust and consistent quality, highlighting real-time monitoring tools that mitigate risks throughout the manufacturing process. Manufacturing innovations, including automated continuous production and 3D printing, further enhance efficiency, scalability, and customization, while sustainable materials address increasing consumer demand for eco-friendly products. Regulatory compliance strategies, focusing on streamlined approval processes and data management, support the expedited market entry of innovative products. The final sections discuss effective marketing approaches and provide case studies of groundbreaking capsule products that have successfully integrated these innovations. This comprehensive analysis offers a roadmap for developing next-generation capsules and identifying emerging trends, such as smart capsules, personalized formulations, and responsiveness.

Keywords

References (15)

  1. Books Received. American Journal of Health-System Pharmacy. 1990;47(9):2150-2151. doi:10.1093/ajhp/47.9.2150a
  2. Enhancement in Drug Delivery. 2006. doi:10.1201/9781420004816
  3. Reichert JM. Trends in development and approval times for new therapeutics in the United States. Nature Reviews Drug Discovery. 2003;2(9):695-702. doi:10.1038/nrd1178
  4. Metwally AA, Hathout RM. Computer-Assisted Drug Formulation Design: Novel Approach in Drug Delivery. Molecular Pharmaceutics. 2015;12(8):2800-2810. doi:10.1021/mp500740d
  5. Vora LK, Gholap AD, Jetha K, Thakur RRS, Solanki HK, Chavda VP. Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. Pharmaceutics. 2023;15(7):1916. doi:10.3390/pharmaceutics15071916
  6. Peanparkdee M, Iwamoto S, Yamauchi R. Microencapsulation: a review of applications in the food and pharmaceutical industries. Reviews in Agricultural Science. 2016;4:56-65.
  7. Olusanya T, Haj Ahmad R, Ibegbu D, Smith J, Elkordy A. Liposomal Drug Delivery Systems and Anticancer Drugs. Molecules. 2018;23(4):907. doi:10.3390/molecules23040907
  8. Patel R, Yadav BK, Patel G. Progresses in Nano-Enabled Platforms for the Treatment of Vaginal Disorders. Recent Patents on Nanotechnology. 2023;17(3):208-227. doi:10.2174/1872210516666220628150447
  9. Yu LX. Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control. Pharmaceutical Research. 2008;25(4):781-791. doi:10.1007/s11095-007-9511-1
  10. FDA (2009). Guidance for Industry: Q8 (R2) Pharmaceutical Development. Retrieved from https://www.fda.gov.
  11. Alavizadeh SH, Soltani F, Ramezani M. Recent Advances in Immunoliposome-Based Cancer Therapy. Current Pharmacology Reports. 2016;2(3):129-141. doi:10.1007/s40495-016-0056-z
  12. Lee SL, O’Connor TF, Yang X, Cruz CN, Chatterjee S, Madurawe RD, et al. Modernizing Pharmaceutical Manufacturing: from Batch to Continuous Production. Journal of Pharmaceutical Innovation. 2015;10(3):191-199. doi:10.1007/s12247-015-9215-8
  13. Qiu, Y., et al. (2009). Qiu Y, Zhang G. Development of modified-release solid oral dosage forms. InDeveloping Solid Oral Dosage Forms 2009 Jan 1 (pp. 501-517). Academic Press.
  14. Chang X, Xu Y, von Delius M. Recent advances in supramolecular fullerene chemistry. Chemical Society Reviews. 2024;53(1):47-83. doi:10.1039/d2cs00937d
  15. ICH Harmonised Tripartite Guideline (2009). Pharmaceutical Quality System Q10. Retrieved from https://www.ich.org.
Support